GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Price-to-Owner-Earnings

Ibnsina Pharma (CAI:ISPH) Price-to-Owner-Earnings : (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Price-to-Owner-Earnings?

As of today (2024-06-06), Ibnsina Pharma's share price is E£2.60. Ibnsina Pharma does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Ibnsina Pharma's Price-to-Owner-Earnings or its related term are showing as below:

During the past 9 years, the highest Price-to-Owner-Earnings of Ibnsina Pharma was 18.64. The lowest was 0.00. And the median was 9.73.


CAI:ISPH's Price-to-Owner-Earnings is not ranked *
in the Medical Distribution industry.
Industry Median: 12.59
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-06), Ibnsina Pharma's share price is E£2.60. Ibnsina Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was E£0.17. Therefore, Ibnsina Pharma's PE Ratio for today is 15.48.

As of today (2024-06-06), Ibnsina Pharma's share price is E£2.60. Ibnsina Pharma's EPS without NRI for the trailing twelve months (TTM) ended in was E£0.13. Therefore, Ibnsina Pharma's PE Ratio without NRI for today is 20.31.

During the past 9 years, Ibnsina Pharma's highest PE Ratio without NRI was 53.19. The lowest was 6.03. And the median was 24.58.


Ibnsina Pharma Price-to-Owner-Earnings Historical Data

The historical data trend for Ibnsina Pharma's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Price-to-Owner-Earnings Chart

Ibnsina Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - - - -

Ibnsina Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ibnsina Pharma's Price-to-Owner-Earnings

For the Medical Distribution subindustry, Ibnsina Pharma's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibnsina Pharma's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Ibnsina Pharma's Price-to-Owner-Earnings falls into.



Ibnsina Pharma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Ibnsina Pharma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.60/-0.21
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibnsina Pharma  (CAI:ISPH) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Ibnsina Pharma Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibnsina Pharma (CAI:ISPH) Business Description

Traded in Other Exchanges
N/A
Address
Industrial zone 1, PO box 91, Obour, EGY
Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines